Panel Discussion: Opportunities & Challenges to Optimize In Vivo RNA Engineering

Time: 10:30 am
day: Day Two


  • Elucidating the opportunities for in vivo cell therapy to minimize current ex vivo bottlenecks and the role of RNA engineering in producing versatile therapies
  • Achieving a transient vs. longer term effect for different indications with RNA modification
  • Maintaining consistent in vivo production of RNA to yield long-term responses